+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Glaucoma Surgery Devices Market 2021-2025

  • PDF Icon

    Report

  • 120 Pages
  • August 2021
  • Region: Global
  • TechNavio
  • ID: 5011372
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The publisher has been monitoring the glaucoma surgery devices market and it is poised to grow by $1.40 bn during 2021-2025, decelerating at a CAGR of 26.41% during the forecast period. The report on the glaucoma surgery devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of glaucoma and rapid technological advances.

The glaucoma surgery devices market analysis includes the product segment and geographic landscape.

The glaucoma surgery devices market is segmented as below:


By Product

  • MIGS devices
  • Laser therapy devices
  • Conventional therapy devices

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • ROW

This study identifies the increasing initiatives for customer training and awareness as one of the prime reasons driving the glaucoma surgery devices market growth during the next few years.

The report on glaucoma surgery devices market covers the following areas:

  • Glaucoma surgery devices market sizing
  • Glaucoma surgery devices market forecast
  • Glaucoma surgery devices market industry analysis

The publisher's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading glaucoma surgery devices market vendors that include AbbVie Inc., Carl Zeiss AG, IRIDEX Corp., Johnson and Johnson Inc., Lumenis Ltd., Nova Eye Medical Ltd., Quantel Medical, Santen Pharmaceutical Co. Ltd., and Sight Sciences Inc. Also, the glaucoma surgery devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

Executive Summary

  • Market overview

Market Landscape

  • Market ecosystem
  • Value chain analysis

Market Sizing

  • Market definition
  • Market segment analysis
  • Market size 2020
  • Market outlook: Forecast for 2020 - 2025

Five Forces Analysis

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by Product

  • Market segments
  • Comparison by Product
  • MIGS devices - Market size and forecast 2020-2025
  • Laser therapy devices - Market size and forecast 2020-2025
  • Conventional therapy devices - Market size and forecast 2020-2025
  • Market opportunity by Product

Customer landscape

Geographic Landscape

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2020-2025
  • Europe - Market size and forecast 2020-2025
  • Asia - Market size and forecast 2020-2025
  • ROW - Market size and forecast 2020-2025
  • Key leading countries
  • Market opportunity By Geographical Landscape
  • Market drivers
  • Market challenges
  • Market trends

Vendor Landscape

  • Overview
  • Landscape disruption

Vendor Analysis

  • Vendors covered
  • Market positioning of vendors
  • AbbVie Inc.
  • Carl Zeiss AG
  • IRIDEX Corp.
  • Johnson and Johnson Inc.
  • Lumenis Ltd.
  • Nova Eye Medical Ltd.
  • Quantel Medical
  • Santen Pharmaceutical Co. Ltd.
  • Sight Sciences Inc.

Appendix

  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

Exhibits

  • Key Finding 1
  • Key Finding 2
  • Key Finding 3
  • Key Finding 5
  • Key Finding 6
  • Key Finding 7
  • Key Finding 8
  • Parent market
  • Market characteristics
  • Offerings of vendors included in the market definition
  • Market segments
  • Global - Market size and forecast 2020 - 2025 ($ million)
  • Global market: Year-over-year growth 2020 - 2025 (%)
  • Five forces analysis 2020 & 2025
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition - Five forces 2020
  • Product - Market share 2020-2025 (%)
  • Comparison by Product
  • MIGS devices - Market size and forecast 2020-2025 ($ million)
  • MIGS devices - Year-over-year growth 2020-2025 (%)
  • Laser therapy devices - Market size and forecast 2020-2025 ($ million)
  • Laser therapy devices - Year-over-year growth 2020-2025 (%)
  • Conventional therapy devices - Market size and forecast 2020-2025 ($ million)
  • Conventional therapy devices - Year-over-year growth 2020-2025 (%)
  • Market opportunity by Product
  • Customer landscape
  • Market share By Geographical Landscape 2020-2025 (%)
  • Geographic comparison
  • North America - Market size and forecast 2020-2025 ($ million)
  • North America - Year-over-year growth 2020-2025 (%)
  • Europe - Market size and forecast 2020-2025 ($ million)
  • Europe - Year-over-year growth 2020-2025 (%)
  • Asia - Market size and forecast 2020-2025 ($ million)
  • Asia - Year-over-year growth 2020-2025 (%)
  • ROW - Market size and forecast 2020-2025 ($ million)
  • ROW - Year-over-year growth 2020-2025 (%)
  • Key leading countries
  • Market opportunity By Geographical Landscape ($ million)
  • Impact of drivers and challenges
  • Vendor landscape
  • Landscape disruption
  • Industry risks
  • Vendors covered
  • Market positioning of vendors
  • AbbVie Inc. - Overview
  • AbbVie Inc. - Product and service
  • AbbVie Inc. - Key offerings
  • AbbVie Inc. - Key customers
  • AbbVie Inc. - Segment focus
  • Carl Zeiss AG - Overview
  • Carl Zeiss AG - Business segments
  • Carl Zeiss AG - Key offerings
  • Carl Zeiss AG - Key customers
  • Carl Zeiss AG - Segment focus
  • IRIDEX Corp. - Overview
  • IRIDEX Corp. - Business segments
  • IRIDEX Corp. - Key offerings
  • IRIDEX Corp. - Key customers
  • IRIDEX Corp. - Segment focus
  • Johnson and Johnson Inc. - Overview
  • Johnson and Johnson Inc. - Business segments
  • Johnson and Johnson Inc. - Key offerings
  • Johnson and Johnson Inc. - Key customers
  • Johnson and Johnson Inc. - Segment focus
  • Lumenis Ltd. - Overview
  • Lumenis Ltd. - Product and service
  • Lumenis Ltd. - Key offerings
  • Lumenis Ltd. - Key customers
  • Lumenis Ltd. - Segment focus
  • Nova Eye Medical Ltd. - Overview
  • Nova Eye Medical Ltd. - Product and service
  • Nova Eye Medical Ltd. - Key offerings
  • Nova Eye Medical Ltd. - Key customers
  • Nova Eye Medical Ltd. - Segment focus
  • Quantel Medical - Overview
  • Quantel Medical - Product and service
  • Quantel Medical - Key offerings
  • Quantel Medical - Key customers
  • Quantel Medical - Segment focus
  • Santen Pharmaceutical Co. Ltd. - Overview
  • Santen Pharmaceutical Co. Ltd. - Business segments
  • Santen Pharmaceutical Co. Ltd. - Key offerings
  • Santen Pharmaceutical Co. Ltd. - Key customers
  • Santen Pharmaceutical Co. Ltd. - Segment focus
  • Sight Sciences Inc. - Overview
  • Sight Sciences Inc. - Product and service
  • Sight Sciences Inc. - Key offerings
  • Sight Sciences Inc. - Key customers
  • Sight Sciences Inc. - Segment focus
  • Currency conversion rates for US$
  • Research Methodology
  • Validation techniques employed for market sizing
  • Information sources
  • List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global glaucoma surgery devices market: AbbVie Inc., Carl Zeiss AG, IRIDEX Corp., Johnson and Johnson Inc., Lumenis Ltd., Nova Eye Medical Ltd., Quantel Medical, Santen Pharmaceutical Co. Ltd., and Sight Sciences Inc.

Commenting on the report, an analyst from the research team said: `The latest trend gaining momentum in the market is increasing initiatives for customer training and awareness.`

According to the report, one of the major drivers for this market is the increasing prevalence of glaucoma.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned

A selection of companies mentioned in this report includes:

  • AbbVie Inc.
  • Carl Zeiss AG
  • IRIDEX Corp.
  • Johnson and Johnson Inc.
  • Lumenis Ltd.
  • Nova Eye Medical Ltd.
  • Quantel Medical
  • Santen Pharmaceutical Co. Ltd.
  • Sight Sciences Inc.